Reference: GILA/ID/AUD-029/WINDOEM
Board seat: Independent Director, Non-Executive
Primary board location: Chennai and southern manufacturing sites
Meeting model: Six Audit meetings, five boards and quarterly warranty reviews
Mandate type: Audit Committee Chair & Financial Expert
Status: Confidential live-search specification; client identity released only after conflict clearance and NDA.
The anonymised enterprise
A listed manufacturer of large castings, blades and nacelle subassemblies supplied to global wind-turbine OEMs under long-term quality and volume programmes.
Revenue is ₹4,000–5,500 crore with substantial export receivables and customer-specific tooling. A rapid move to larger turbine platforms raises yield, warranty and capex risk.
The board problem and strategic reason for appointment
The Audit Committee needs a chair who can challenge contract modifications, take-or-pay assumptions, tooling ownership, quality escapes and serial warranty exposure before these become delayed provisions.
The board is not buying a credential. It is appointing an independent decision-maker who can convert this problem into a governed sequence of choices, evidence and accountability. Success will be judged by the quality of decisions and control improvement, not by the number of recommendations made.
Board position, authority and interfaces
Audit Committee Chair; Risk member; direct sessions with quality, customer-programme finance and internal audit.
The appointee will have direct, unfiltered access to the Company Secretary and to the relevant control-function leaders. Any advisory support requested by the board must remain management-executed: the director sets questions, tolerances and evidence standards, but does not become an executive or consultant.
First 12–18 month strategic charter
- Review contract assets, volume assumptions and customer claims by programme; test warranty provisioning using failure modes and field cohorts rather than historical percentage alone; clarify ownership and impairment of customer tooling and platform-specific capex; examine export receivables, currency hedges and customer concentration under programme delay
- Reset the Audit Committee agenda around judgement-heavy accounting, cash conversion, control exceptions, related parties, audit quality and closure evidence instead of receiving compliance presentations.
- Establish private sessions with the statutory auditor, internal auditor, CFO and whistleblower function; define escalation triggers and protect the independence of each control function.
Decision profile sought
Essential evidence
- Manufacturing CFO, industrial audit partner or wind/auto/aerospace programme-finance leader; Audit Chair record; warranty and contract-accounting depth
Differentiators
- Large-casting, composite or global OEM qualification experience; field-failure remediation leadership
GILA will assess audit-chair temperament, forensic curiosity, accounting depth relevant to the business model, and the courage to slow a transaction or close when evidence is weak. Candidates should expect a case discussion based on an ambiguous board decision from this mandate, not a career-history interview alone.
Independence, suitability and downside diligence
The search will apply Section 149(6), Sections 164–165, Schedule IV and the applicable listing or sector rules to the entity’s legally verified status at the appointment date. Databank/proficiency status, listed-entity directorship and committee ceilings, pecuniary relationships, relatives’ interests, recent audit/advisory work and interlocking directorships will be checked. The appointment is subject to formal legal and secretarial confirmation; this posting is not a substitute for that determination.
Mandate-specific screens: Current OEM procurement influence, tooling-vendor interests, direct component competitor seats or recent audit relationship.
Before accepting the seat, the candidate will receive under NDA the latest board composition, committee charters, material litigation/regulatory schedule, related-party map, last audited accounts, current D&O policy and the specific risk papers necessary to make an informed liability assessment.
Twelve-month outcomes
The board expects an Audit Committee that can explain the economic substance behind the numbers and prove that exceptions were closed, not narrated away. For this particular seat, the evidence will be:
- Warranty model tied to field evidence; programme capital and tooling ownership documented; claims, hedges and concentration downside visible before close
Commitment, protection and economics
- Expected load: 22–28 days annually.
- Terms: Five-year term; chair premium; product recall, export and securities D&O protection.
- Protection: Appointment letter, deed of indemnity where legally available, appropriate D&O cover including discovery/run-off terms, access to independent advice under the board-approved protocol, and complete minuting of dissent.
- Equity: No stock options where the appointment is legally an independent-director seat subject to Section 149(9). Any private-company structure outside that perimeter will be expressly classified and separately advised; no equity is implied by this posting.
Search process
Conflict pre-clearance → GILA/SYMPHONY™ board-fit interview → mandate case → document-led diligence under NDA → references from board peers and control functions → NRC/owner interviews → statutory, regulatory and reputation checks → board recommendation. Candidate consent, disclosures and appointment approvals will follow the law and the entity’s constitutional documents.